The impact of Germany’s human papillomavirus immunization program on HPV-related anogenital diseases - a retrospective analysis of claims data from statutory health insurances
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
